ESR2 and triple-negative breast carcinoma: Although triple-negative breast cancers lack the ER-α and full-length splicing variant of ER-β, the ER-β1, and ER-β2 were reported to be expressed in the triple-negative breast cancer cell line MDA-MB-231 [25].